July 19, 2023

BOTANNIS LABS NY INC. RECEIVES ZERO OBSERVATIONS DURING U.S. FDA FACILITY INSPECTION

HAUPPAUGE, N.Y., July 19, 2023 (Newswire.com) – Botannis Labs NY Inc. is delighted to announce the successful completion of a facility inspection by the U.S. Food and Drug Administration (FDA), the leading regulatory body overseeing the nutraceutical and pharmaceutical industries. The successful inspection validates Botannis’ commitment to delivering exceptional analytical testing services. This was a routine […]

Read More…

July 12, 2023

BOTANNIS LABS, INC., RECEIVES CANNABINOIDS AND TERPENES TESTING PERMIT FROM NYS OFFICE OF CANNABIS MANAGEMENT

HAUPPAUGE, N.Y., July 12, 2023 (Newswire.com) – Botannis Labs, Inc., a leading provider of analytical testing services for the nutraceutical and pharmaceutical industries, is pleased to announce that the Hauppauge, Long Island-based testing laboratory received approval for testing of cannabinoids and terpenes last month from the New York State Office of Cannabis Management (OCM). As only one […]

Read More…

June 2, 2023

BOTANNIS LABS, INC. CEO NAMED TO POLITICS NY CANNABIS INDUSTRY POWER PLAYERS LIST

HAUPPAUGE, NY (June 2, 2023) – Botannis Labs, Inc., a leading provider of analytical testing services for the nutraceutical and pharmaceutical industries, is proud to announce that CEO, Matt Wolf, has been named to Schneps Media’s Politics NY and amNewYork Metro’s 2023 Cannabis Industry Power Players list for his work in leading the cannabis industry […]

Read More…

May 30, 2023

BOTANNIS LABS, INC. APPROVED IN NEW YORK STATE FOR CONTROLLED SUBSTANCE LABORATORY TESTING

HAUPPAUGE, NY / ACCESSWIRE / May 24, 2023 / Botannis Labs, Inc., a leading provider of analytical testing services for the nutraceutical and pharmaceutical industries, is excited to announce the opening of its new testing facility in Hauppauge, Long Island, NY. The facility will provide comprehensive testing services, offering the industry’s highest level of expertise, […]

Read More…